Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
Boston Scientific has high hopes for its breakthrough S-ICD product, the first and only approved subcutaneous implantable cardioverter defibrillator that has no leads in the heart. The product came to ...
May 27, 2005-- Guidant Corporation (Indianapolis, Indiana) sent a letter to physicians this week informing them about a potential shorting defect in certain models of the company's PRIZM 2 DR ...
SAN DIEGO, CA—Use of a subcutaneous implantable cardioverter-defibrillator (S-ICD) appears to have some advantages over transvenous devices for patients with an ICD indication but no need for pacing, ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Subcutaneous implantable cardioverter ...
S-ICD defibrillator: implantable device shocks irregular heartbeats to return them to normal rhythm San Clemente-based Cameron Health Inc. last week cleared a regulatory hurdle on the way to its sale ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. An extravascular implantable cardioverter defibrillator ...
In an interview, a senior Boston Scientific executive shares new information on the company's competing device to Medtronic's Micra and St. Jude Medical's Nanostim leadless pacemakers. We know about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback